Kärnell A, Li A, Zhao C R, Karlsson K, Nguyen B M, Lindberg A A
Karolinska Institute, Department of Immunology, Microbiology, Pathology and Infectious Diseases, Huddinge Hospital, Sweden.
Vaccine. 1995 Jan;13(1):88-99. doi: 10.1016/0264-410x(95)80017-8.
The live auxotrophic Shigella flexneri 2a vaccine strain SFL1070 with a deleted aroD gene was given orally to 37 adult Swedish volunteers who received three doses within 5 days. Each dose comprised 1 x 10(5) (n = 9), 1 x 10(7) (n = 10), 1 x 10(8) (n = 9) or 1 x 10(9) (n = 9) c.f.u. S. flexneri SFL1070. One volunteer vaccinated with 1 x 10(7) and three vaccinated with 1 x 10(8) c.f.u. reported mild gastrointestinal symptoms after the first dose. Vaccination with 1 x 10(9) c.f.u. caused abdominal pain and watery diarrhoea in four volunteers who all recovered spontaneously within 72 h. S. flexneri SFL1070 was not recovered from volunteers given 1 x 10(5) c.f.u., but was shed in faeces by six volunteers vaccinated with 1 x 10(7), by all nine vaccinated with 1 x 10(8), and by seven volunteers vaccinated with 1 x 10(9) c.f.u. The mean excretion time was 2.6 (range 0-4) days in the 1 x 10(8) and the 1 x 10(9) groups. Serum antibody responses against either S. flexneri 2a and Y lipopolysaccharides (LPSs) or Shigella invasion plasmid antigens (Ipa) were seen in eight volunteers vaccinated with 1 x 10(9) (p < 0.01 to p < 0.05 for mean relative titres of IgA and IgG against S. flexneri 2a and Y LPSs), in four vaccinated with 1 x 10(8), and in two and one volunteers each vaccinated with 1 x 10(7) and 1 x 10(5) c.f.u. of S. flexneri SFL1070. Intestinal sIgA responses to the same antigens were elicited in all volunteers in the 1 x 10(9) and the 1 x 10(8) groups, and in six and one volunteers vaccinated with 1 x 10(7) and 1 x 10(5) c.f.u., respectively. The sIgA responses against S. flexneri 2a and Y LPSs were significant in all but the 1 x 10(5) group (p < 0.01 to p < 0.05). Significant antibody-secreting cell (ASC) responses specific to S. flexneri 2a LPS were seen in peripheral blood from eight volunteers each in the 1 x 10(9) and 1 x 10(8) groups and from five volunteers vaccinated with 1 x 10(7) c.f.u. (p < 0.01 to p < 0.05). The number of volunteers showing anti-Shigella Ipa ASC responses in these groups were five (p < 0.01 to p < 0.05), three and one, respectively.(ABSTRACT TRUNCATED AT 400 WORDS)
将缺失aroD基因的活营养缺陷型福氏志贺菌2a疫苗株SFL1070口服给予37名成年瑞典志愿者,他们在5天内接受了三剂疫苗。每剂包含1×10⁵(n = 9)、1×10⁷(n = 10)、1×10⁸(n = 9)或1×10⁹(n = 9)cfu的福氏志贺菌SFL1070。一名接种1×10⁷cfu的志愿者和三名接种1×10⁸cfu的志愿者在首剂后报告有轻度胃肠道症状。接种1×10⁹cfu导致四名志愿者出现腹痛和水样腹泻,他们均在72小时内自发康复。给予1×10⁵cfu的志愿者粪便中未检出福氏志贺菌SFL1070,但接种1×10⁷cfu的六名志愿者、接种1×10⁸cfu的所有九名志愿者以及接种1×10⁹cfu的七名志愿者粪便中有该菌排出。1×10⁸和1×10⁹组的平均排泄时间为2.6天(范围0 - 4天)。在接种1×10⁹cfu的八名志愿者中观察到针对福氏志贺菌2a和Y型脂多糖(LPS)或志贺菌侵袭质粒抗原(Ipa)的血清抗体反应(针对福氏志贺菌2a和Y型LPS的IgA和IgG平均相对滴度,p < 0.01至p < 0.05),接种1×10⁸cfu的四名志愿者,以及接种1×10⁷cfu和1×10⁵cfu福氏志贺菌SFLP07的志愿者分别为两名和一名。1×10⁹和1×10⁸组的所有志愿者均引发了针对相同抗原的肠道sIgA反应,接种1×10⁷cfu和1×10⁵cfu的志愿者分别有六名和一名出现该反应。除1×10⁵组外,针对福氏志贺菌2a和Y型LPS的sIgA反应均显著(p < 0.01至p < 0.05)。在1×10⁹和1×10⁸组的八名志愿者以及接种1×10⁷cfu的五名志愿者的外周血中观察到针对福氏志贺菌2a LPS的显著抗体分泌细胞(ASC)反应(p < 0.01至p < 0.05)。这些组中出现抗志贺菌Ipa ASC反应的志愿者人数分别为五名(p < 0.01至p < 0.05)、三名和一名。(摘要截选至400字)